What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Mauro Maccarrone mostly deals with Endocannabinoid system, Anandamide, Cannabinoid receptor, Cannabinoid and Endocrinology.
His Endocannabinoid system study incorporates themes from Signal transduction, Cell biology and Neuroscience.
His Anandamide study combines topics from a wide range of disciplines, such as Cannabinoid Receptor Modulators, TRPV1, 2-Arachidonoylglycerol, Pharmacology and Fatty acid amide hydrolase.
In his research, Fertility, Offspring and Mammalian reproduction is intimately related to Lipid signaling, which falls under the overarching field of Cannabinoid receptor.
The study incorporates disciplines such as Capsazepine, Endothelial stem cell, Cannabinoid receptor antagonist, Glutamatergic and Central nervous system in addition to Cannabinoid.
His Endocrinology research is multidisciplinary, incorporating elements of Internal medicine, Gene expression and Methanandamide.
His most cited work include:
- Endocannabinoid signaling at the periphery: 50 years after THC (348 citations)
- The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism (324 citations)
- Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. (313 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Endocannabinoid system, Cannabinoid receptor, Anandamide, Biochemistry and Internal medicine.
His research integrates issues of Cannabinoid, Neuroscience, Fatty acid amide hydrolase and Cell biology in his study of Endocannabinoid system.
His research in Cell biology intersects with topics in Apoptosis, Programmed cell death and Immune system.
His biological study spans a wide range of topics, including Signal transduction, TRPV1 and Pharmacology.
His Anandamide research is multidisciplinary, incorporating perspectives in Lipid signaling, Transporter, 2-Arachidonoylglycerol, Immunology and Intracellular.
In his work, DNA methylation and Epigenetics is strongly intertwined with Endocrinology, which is a subfield of Internal medicine.
He most often published in these fields:
- Endocannabinoid system (49.04%)
- Cannabinoid receptor (31.24%)
- Anandamide (29.67%)
What were the highlights of his more recent work (between 2016-2021)?
- Endocannabinoid system (49.04%)
- Cannabinoid receptor (31.24%)
- Receptor (18.50%)
In recent papers he was focusing on the following fields of study:
Mauro Maccarrone focuses on Endocannabinoid system, Cannabinoid receptor, Receptor, Cell biology and Neuroscience.
His Endocannabinoid system research includes elements of Anandamide, Endocrinology, 2-Arachidonoylglycerol and Fatty acid amide hydrolase.
Cannabinoid receptor is a subfield of Internal medicine that Mauro Maccarrone tackles.
His work carried out in the field of Receptor brings together such families of science as Lipopolysaccharide and Signal transduction.
His Cell biology research includes themes of Inflammation, TRPV1, Immune system, Endogeny and Epigenetics.
His research in Neuroscience focuses on subjects like Neurodegeneration, which are connected to Neuroprotection and Multiple sclerosis.
Between 2016 and 2021, his most popular works were:
- Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 (155 citations)
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity (140 citations)
- Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. (123 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Endocannabinoid system, Neuroscience, Internal medicine, Receptor and Cannabinoid receptor.
The various areas that Mauro Maccarrone examines in his Endocannabinoid system study include Lipid signaling, DNA methylation, Multiple sclerosis, Hippocampus and Cannabis.
His Internal medicine research is multidisciplinary, relying on both Endocrinology, Blastocoel, Polyunsaturated fatty acid and CpG site.
His Receptor study integrates concerns from other disciplines, such as Metabolic enzymes, Signal transduction and Computational biology.
The Cannabinoid receptor study combines topics in areas such as Neuroinflammation, Cannabinoid and Cannabidiol.
His Cannabinoid study combines topics in areas such as Neurodegeneration, Disease and Neuroprotection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
